Jon P. Stonehouse - Dec 14, 2021 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role: President & CEO, Director
Signature: /s/ Alane P. Barnes, by power of attorney
Stock symbol: BCRX
Transactions as of: Dec 14, 2021
Transactions value $: $0
Form type: 4
Date filed: 12/16/2021, 03:53 PM
Previous filing: Jul 7, 2021
Next filing: Sep 1, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BCRX	Common Stock	Gift	$0	-5K	-0.63%	$0.00	784K	Sep 1, 2021	Direct	F1
transaction	BCRX	Common Stock	Gift	$0	-5K	-0.64%	$0.00	779K	Sep 1, 2021	Direct	F2
transaction	BCRX	Common Stock	Gift	$0	+5K		$0.00	5K	Sep 1, 2021	By wife as co-trustee of the Samuel Stonehouse Irrevocable Trust	F1
transaction	BCRX	Common Stock	Gift	$0	+5K		$0.00	5K	Sep 1, 2021	By wife as co-trustee of the Caroline Stonehouse Irrevocable Trust	F2
transaction	BCRX	Common Stock	Award	$0	+123K	+15.8%	$0.00	902K	Dec 14, 2021	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BCRX	Emp. Stock Option (Right to Buy)	Award	$0	+575K		$0.00	575K	Dec 14, 2021	Common Stock	575K	$11.43	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects a gift of shares by the reporting person to the Samuel Stonehouse Irrevocable Trust.
F2	Reflects a gift of shares by the reporting person to the Caroline Stonehouse Irrevocable Trust.
F3	Annual award of Restricted Stock Units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant.
F4	Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.